证券记录 · 已归档季度
RAPP
Rapport Therapeutics, Inc. Common Stock · Healthcare · Biotechnology
16被追踪持有人
+4Δ持有人
15.68M持有股份
$465.84M报告持仓市值
+4新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +30.0% ·
股份流向 +23.2% ·
净新建仓位 +20.0%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 69 | +3 | 25.15M | $1.04B | +5 | −2 |
| Q1 2026 | 69 | +1 | 25.07M | $783.61M | +5 | −4 |
| Q4 2025 | 68 | +1 | 25.43M | $771.51M | +1 | — |
| Q3 2025 | 16 | +4 | 15.68M | $465.84M | +4 | — |
| Q2 2025 | 9 | +1 | 10.01M | $113.83M | +2 | −1 |
| Q1 2025 | 5 | 0 | 1.86M | $18.69M | +1 | −1 |
| Q4 2024 | 5 | 0 | 2.06M | $36.50M | — | — |
| Q3 2024 | 4 | -2 | 1.81M | $36.50M | +1 | −3 |
| Q2 2024 | 6 | — | 2.18M | $50.21M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 6.92M | +26.4% | $205.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 6.92M | +26.4% | $205.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Goldman Sachs Group ✦ | 2.42M | — | $71.93M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Goldman Sachs Group ✦ | 2.42M | — | $71.93M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (被动) | 1.63M | +46.9% | $48.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | The Vanguard Group ✦ (被动) | 1.63M | +46.9% | $48.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | The Vanguard Group ✦ (被动) | 1.63M | +46.9% | $48.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 1.57M | +28.6% | $46.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 1.57M | +28.6% | $46.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 1.57M | +28.6% | $46.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 1.57M | +28.6% | $46.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 1.57M | +28.6% | $46.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 1.57M | +28.6% | $46.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 1.57M | +28.6% | $46.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 1.10M | -27.7% | $32.74M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 1.10M | -27.7% | $32.74M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 17 | Geode Capital Management ✦ (被动) | 533.40K | +60.1% | $15.85M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Geode Capital Management ✦ (被动) | 533.40K | +60.1% | $15.85M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | Adage Capital Partners ✦ | 450.00K | 新增 | $13.37M | 0.0% | New | 1 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (被动) | 371.63K | +24.4% | $11.04M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 274.57K | — | $8.15M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 274.57K | — | $8.15M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 274.57K | — | $8.15M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 274.57K | — | $8.15M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 274.57K | — | $8.15M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Millennium Management ✦ | 154.17K | 新增 | $4.58M | 0.0% | New | 1 | SEC ↗ |
| 27 | Citadel Advisors ✦ | 104.88K | 新增 | $3.11M | 0.0% | New | 1 | SEC ↗ |
| 28 | Citadel Advisors ✦ | 104.88K | 新增 | $3.11M | 0.0% | New | 1 | SEC ↗ |
| 29 | Wellington Management ✦ | 62.82K | 新增 | $1.87M | 0.0% | New | 1 | SEC ↗ |
| 30 | Wellington Management ✦ | 62.82K | 新增 | $1.87M | 0.0% | New | 1 | SEC ↗ |
| 31 | Wellington Management ✦ | 62.82K | 新增 | $1.87M | 0.0% | New | 1 | SEC ↗ |
| 32 | Renaissance Technologies ✦ | 35.30K | +126.3% | $1.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 33 | Two Sigma Investments ✦ | 21.50K | +8.9% | $638,550 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 20.62K | +21.5% | $612,474 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 20.62K | +21.5% | $612,474 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 20.62K | +21.5% | $612,474 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 20.62K | +21.5% | $612,474 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 19.97K | — | $593,048 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 19.97K | — | $593,048 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 19.97K | — | $593,048 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 19.97K | — | $593,048 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 19.97K | — | $593,048 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 19.97K | — | $593,048 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Adage Capital Partners | $13.37M | 0.0% |
| Millennium Management | $4.58M | 0.0% |
| Citadel Advisors | $3.11M | 0.0% |
| Citadel Advisors | $3.11M | 0.0% |
| Wellington Management | $1.87M | 0.0% |
| Wellington Management | $1.87M | 0.0% |
| Wellington Management | $1.87M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 146 持有人, 52.47M 股份, $1.59B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 19
Yeleswaram Krishnaswamy
Officer · 404 股 · $20,160
Aug 11
Ceesay Abraham
Officer, Director · 3.66K 股 · $171,837
Aug 11
Ceesay Abraham
Officer, Director · 19.50K 股 · $936,846
Aug 11
Ceesay Abraham
Officer, Director · 5.79K 股 · $281,721
Aug 10
Ceesay Abraham
Officer, Director · 14.17K 股 · $651,492
Aug 10
Ceesay Abraham
Officer, Director · 8.37K 股 · $391,280
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G/A — Third Rock Ventures V, L.P.
Aug 14
SC 13G/A — Cormorant Asset Management, LP
Aug 12
SC 13G/A — Capital International Investors
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据